IN191359B - - Google Patents

Info

Publication number
IN191359B
IN191359B IN607DE1999A IN191359B IN 191359 B IN191359 B IN 191359B IN 607DE1999 A IN607DE1999 A IN 607DE1999A IN 191359 B IN191359 B IN 191359B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Shakti Nath Upadhyay
Vikas Madan
Original Assignee
Nat Inst Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Inst Immunology filed Critical Nat Inst Immunology
Priority to IN607DE1999 priority Critical patent/IN191359B/en
Priority to US09/339,759 priority patent/US6251383B1/en
Publication of IN191359B publication Critical patent/IN191359B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/76Undefined extracts from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394Bone marrow stromal cells; whole marrow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN607DE1999 1999-04-20 1999-04-20 IN191359B (US20090226406A1-20090910-C00003.png)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN607DE1999 IN191359B (US20090226406A1-20090910-C00003.png) 1999-04-20 1999-04-20
US09/339,759 US6251383B1 (en) 1999-04-20 1999-06-24 Method for ex-vivo expansion of hematopoietic cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN607DE1999 IN191359B (US20090226406A1-20090910-C00003.png) 1999-04-20 1999-04-20

Publications (1)

Publication Number Publication Date
IN191359B true IN191359B (US20090226406A1-20090910-C00003.png) 2003-11-29

Family

ID=11090508

Family Applications (1)

Application Number Title Priority Date Filing Date
IN607DE1999 IN191359B (US20090226406A1-20090910-C00003.png) 1999-04-20 1999-04-20

Country Status (2)

Country Link
US (1) US6251383B1 (US20090226406A1-20090910-C00003.png)
IN (1) IN191359B (US20090226406A1-20090910-C00003.png)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1349918B1 (en) 2000-12-06 2014-08-06 Anthrogenesis Corporation Method of collecting placental stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
CA2856986C (en) 2001-02-14 2019-08-13 Anthrogenesis Corporation Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
WO2003102151A2 (en) * 2002-05-30 2003-12-11 Celgene Corporation Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors
AU2003304210A1 (en) * 2002-10-04 2005-01-04 Embiosis Pharmaceuticals Method of amplifying metabolically inactive bacteria
CN1717177A (zh) 2002-11-26 2006-01-04 人类起源公司 细胞治疗剂、细胞治疗单元及其用于治疗的方法
JP4571952B2 (ja) * 2004-02-05 2010-10-27 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー 抗アレルギー組成物及び関連方法
CN1921874B (zh) * 2004-04-09 2012-08-08 皮拉马尔生命科学有限公司 用于肾病的草药提取物
US20060045923A1 (en) * 2004-09-02 2006-03-02 Lal Hingorani Composition containing tinospora cordifolia and process for obtaining same
PE20070771A1 (es) 2005-10-13 2007-08-11 Anthrogenesis Corp Inmunomodulacion mediante el uso de celulas madres de la placenta
CA2633775A1 (en) 2005-12-29 2007-07-12 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
EP2471904B1 (en) 2005-12-29 2018-10-24 Celularity, Inc. Placental stem cell populations
JP2010516239A (ja) * 2007-01-18 2010-05-20 スオメン プナイネン リスティ,ヴェリパルベル 細胞の産生に対する新規方法および試薬
NZ597779A (en) 2007-02-12 2013-07-26 Anthrogenesis Corp Treatment of inflammatory diseases using placental stem cells
WO2008101215A1 (en) 2007-02-16 2008-08-21 Varian Medical Systems Technologies, Inc. Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
SI2203176T1 (sl) 2007-09-28 2015-04-30 Anthrogenesis Corporation Tumorska supresija z uporabo humanega perfuzata placente in intermediarnih naravnih celic ubijalk, pridobljenih iz humane placente
US20100120142A1 (en) 2008-07-11 2010-05-13 Suomen Punainen Risti Veripalvelu Culture of human embryonic cells
US8828376B2 (en) 2008-08-20 2014-09-09 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
NZ591292A (en) 2008-08-20 2012-10-26 Anthrogenesis Corp Improved cell composition and methods of making the same
US8728805B2 (en) 2008-08-22 2014-05-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
RU2015130665A (ru) 2008-11-19 2018-12-24 Антродженезис Корпорейшн Амниотические адгезивные клетки
MX353489B (es) * 2009-07-02 2018-01-16 Anthrogenesis Corp Metodo para producir eritrocitos sin celulas alimentadoras.
WO2011094181A1 (en) 2010-01-26 2011-08-04 Anthrogenesis Corporation Treatment of bone-related cancers using placental stem cells
PT2556145T (pt) 2010-04-07 2016-10-25 Anthrogenesis Corp Angiogénese usando células estaminais placentárias
WO2011127113A1 (en) 2010-04-08 2011-10-13 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
JP5996533B2 (ja) 2010-07-13 2016-09-21 アントフロゲネシス コーポレーション ナチュラルキラー細胞を生成させる方法
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
AU2012262273B2 (en) 2011-06-01 2017-09-14 Celularity Inc. Treatment of pain using placental stem cells
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
EP2953635A4 (en) 2013-02-05 2016-10-26 Anthrogenesis Corp NATURAL KILLER CELLS FROM PLAZENTA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis

Also Published As

Publication number Publication date
US6251383B1 (en) 2001-06-26

Similar Documents

Publication Publication Date Title
BE2011C004I2 (US20090226406A1-20090910-C00003.png)
BE2010C011I2 (US20090226406A1-20090910-C00003.png)
JP2002526326A5 (US20090226406A1-20090910-C00003.png)
BE1025464I2 (US20090226406A1-20090910-C00003.png)
BE2008C046I2 (US20090226406A1-20090910-C00003.png)
JP2002519497A5 (US20090226406A1-20090910-C00003.png)
JP2002512436A5 (US20090226406A1-20090910-C00003.png)
BRPI0017527B8 (US20090226406A1-20090910-C00003.png)
JP2002527967A5 (US20090226406A1-20090910-C00003.png)
JP2002524942A5 (US20090226406A1-20090910-C00003.png)
BE2008C047I2 (US20090226406A1-20090910-C00003.png)
JP2002507030A5 (US20090226406A1-20090910-C00003.png)
JP2002526000A5 (US20090226406A1-20090910-C00003.png)
JP2002532913A5 (US20090226406A1-20090910-C00003.png)
IN189332B (US20090226406A1-20090910-C00003.png)
IN191359B (US20090226406A1-20090910-C00003.png)
JP2002519505A5 (US20090226406A1-20090910-C00003.png)
JP2002531865A5 (US20090226406A1-20090910-C00003.png)
JP2002515361A5 (US20090226406A1-20090910-C00003.png)
JP2002502729A5 (US20090226406A1-20090910-C00003.png)
BRPI0012675B8 (US20090226406A1-20090910-C00003.png)
JP2001012573A5 (US20090226406A1-20090910-C00003.png)
BRPI0017522A2 (US20090226406A1-20090910-C00003.png)
JP2002507836A5 (US20090226406A1-20090910-C00003.png)
GB9911345D0 (US20090226406A1-20090910-C00003.png)